Literature DB >> 15279762

Substance Use Disorders and Neurologic Illness.

Robert D. Davies1, Christian Thurstone, Kelly Woyewodzic.   

Abstract

Because of the high rates of substance use disorders among the general and clinical populations, and the abuse potential of many medications commonly used in the treatment of neurologic illnesses, the treating neurologist must deal with drug misuse and abuse in practice. The most important tool neurologists must have in their arsenal is the ability to assess for and recognize substance use disorders in their patients. Any treatment plan developed for such patients must include ongoing management of substance abuse issues. After a substance use disorder is diagnosed, the neurologist must make proper referrals to adjunctive support interventions (Alcoholics Anonymous or Narcotics Anonymous) and chemical dependency specialists, and work closely and in collaboration with these components of the patient's overall treatment. The treating neurologist should be aware of the myriad neurologic sequelae of drug use, because most drugs of abuse, including alcohol, can have neurologic manifestations resulting from acute intoxication, acute withdrawal, or chronic use. Drug use (past and present) should be included in the differential diagnosis for any patient with an atypical constellation of symptoms or with isolated neurologic deficits. If the treatment of a neurologic condition requires the use of a potentially addictive substance, particularly when the patient has a history of substance use disorders, then the clinician must minimize the risk of addiction by giving the least addictive substances and developing a plan to manage the use of the drug throughout the treatment period.

Entities:  

Year:  2004        PMID: 15279762     DOI: 10.1007/s11940-996-0032-8

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  54 in total

1.  Orofacial dyskinesia and the alcohol dependence syndrome.

Authors:  J V Lucey; T G Dinan
Journal:  Psychol Med       Date:  1992-02       Impact factor: 7.723

2.  Opioid pseudoaddiction--an iatrogenic syndrome.

Authors:  D E Weissman; J D Haddox
Journal:  Pain       Date:  1989-03       Impact factor: 6.961

3.  Sudden unexpected death in epilepsy in Victoria.

Authors:  K Opeskin; A S Harvey; S M Cordner; S F Berkovic
Journal:  J Clin Neurosci       Date:  2000-01       Impact factor: 1.961

Review 4.  Alcohol and substance abuse.

Authors:  A L McRae; K T Brady; S C Sonne
Journal:  Med Clin North Am       Date:  2001-05       Impact factor: 5.456

Review 5.  Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

Authors:  Andrew D Lawrence; Andrew H Evans; Andrew J Lees
Journal:  Lancet Neurol       Date:  2003-10       Impact factor: 44.182

6.  The time course and significance of cannabis withdrawal.

Authors:  Alan J Budney; Brent A Moore; Ryan G Vandrey; John R Hughes
Journal:  J Abnorm Psychol       Date:  2003-08

7.  Autonomic and peripheral neuropathies in patients with chronic alcoholism. A dose-related toxic effect of alcohol.

Authors:  R Monforte; R Estruch; J Valls-Solé; J Nicolás; J Villalta; A Urbano-Marquez
Journal:  Arch Neurol       Date:  1995-01

Review 8.  Movement disorders.

Authors:  F Cardoso; J Jankovic
Journal:  Neurol Clin       Date:  1993-08       Impact factor: 3.806

9.  Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

Authors:  D V Jeste; M P Caligiuri; J S Paulsen; R K Heaton; J P Lacro; M J Harris; A Bailey; R L Fell; L A McAdams
Journal:  Arch Gen Psychiatry       Date:  1995-09

Review 10.  The health effects of ecstasy: a literature review.

Authors:  Linda R Gowing; Susan M Henry-Edwards; Rodney J Irvine; Robert L Ali
Journal:  Drug Alcohol Rev       Date:  2002-03
View more
  1 in total

1.  Hypertrophic and atrophic scars.

Authors:  J Christian Cather; Jennifer Clay Cather
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.